Literature DB >> 34655015

Investigation of the hepatic mTOR/S6K1/SREBP1 signalling pathway in rats at different ages: from neonates to adults.

Meltem Yalçın1, Mehtap Kaçar2,3.   

Abstract

BACKGROUND: Dysfunctions in the lipogenic process controlled by the hepatic mTOR/S6K1/SREBP-1c signaling pathway may contribute to the pathogenesis of various chronic diseases. In the present study, we aimed to determine age-related changes in the mTOR/S6K1/SREBP1 pathway in rat liver tissues. METHODS AND
RESULTS: We performed Western Blot analysis to determine age-related changes in the mTOR/S6K1/SREBP1 pathway in Sprague Dawley male rats liver tissues of six different age groups representing neonatal, infant, weaning, puberty, young adult, adult life periods, and Oil Red O staining to evaluate age-related lipid accumulation. We observed an increase in Akt and p-Akt levels with age in compared to the 0-day-old group. Total mTOR and SREBP1 expression increased from the 0-day-old to the 28-day-old group but decreased in the following age groups. p-mTOR and p-S6K1 levels in the 0-day-old group were higher than the other groups. S6K1 expression was lowest in the 0-day-old group and showed changes among the age groups. Lipid accumulation was seen in liver sections taken from the 12-month-old group. mTOR/S6K1/SREBP1 pathway expression showed changes with age during the neonatal-adult life cycle stages in rat liver tissues.
CONCLUSION: We suggest that understanding the molecular mechanisms age-related changes of lipogenesis function is necessary to contribute to the development of therapeutic approaches.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Age; Lipogenesis; Liver; SREBP1; mTOR

Mesh:

Substances:

Year:  2021        PMID: 34655015     DOI: 10.1007/s11033-021-06757-4

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  31 in total

1.  Activation of a metabolic gene regulatory network downstream of mTOR complex 1.

Authors:  Katrin Düvel; Jessica L Yecies; Suchithra Menon; Pichai Raman; Alex I Lipovsky; Amanda L Souza; Ellen Triantafellow; Qicheng Ma; Regina Gorski; Stephen Cleaver; Matthew G Vander Heiden; Jeffrey P MacKeigan; Peter M Finan; Clary B Clish; Leon O Murphy; Brendan D Manning
Journal:  Mol Cell       Date:  2010-07-30       Impact factor: 17.970

Review 2.  SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology.

Authors:  Hitoshi Shimano; Ryuichiro Sato
Journal:  Nat Rev Endocrinol       Date:  2017-08-29       Impact factor: 43.330

3.  Insulin stimulation of SREBP-1c processing in transgenic rat hepatocytes requires p70 S6-kinase.

Authors:  Joshua L Owen; Yuanyuan Zhang; Soo-Han Bae; Midhat S Farooqi; Guosheng Liang; Robert E Hammer; Joseph L Goldstein; Michael S Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-27       Impact factor: 11.205

Review 4.  De novo lipogenesis in the liver in health and disease: more than just a shunting yard for glucose.

Authors:  Francis W B Sanders; Julian L Griffin
Journal:  Biol Rev Camb Philos Soc       Date:  2015-03-04

5.  Anti-cancer efficacy of SREBP inhibitor, alone or in combination with docetaxel, in prostate cancer harboring p53 mutations.

Authors:  Xiangyan Li; Jason Boyang Wu; Leland W K Chung; Wen-Chin Huang
Journal:  Oncotarget       Date:  2015-12-01

Review 6.  Non-alcoholic fatty liver disease: An expanded review.

Authors:  Mark Benedict; Xuchen Zhang
Journal:  World J Hepatol       Date:  2017-06-08

7.  Down-regulation of PKM2 decreases FASN expression in bladder cancer cells through AKT/mTOR/SREBP-1c axis.

Authors:  Ting Tao; Qiongli Su; Simeng Xu; Jun Deng; Sichun Zhou; Yu Zhuang; Yanjun Huang; Caimei He; Shanping He; Mei Peng; Berthold Hocher; Xiaoping Yang
Journal:  J Cell Physiol       Date:  2018-09-17       Impact factor: 6.384

8.  SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth.

Authors:  Thomas Porstmann; Claudio R Santos; Beatrice Griffiths; Megan Cully; Mary Wu; Sally Leevers; John R Griffiths; Yuen-Li Chung; Almut Schulze
Journal:  Cell Metab       Date:  2008-09       Impact factor: 27.287

9.  ESRP2 controls an adult splicing programme in hepatocytes to support postnatal liver maturation.

Authors:  Amruta Bhate; Darren J Parker; Thomas W Bebee; Jaegyoon Ahn; Waqar Arif; Edrees H Rashan; Sandip Chorghade; Anthony Chau; Jae-Hyung Lee; Sayeepriyadarshini Anakk; Russ P Carstens; Xinshu Xiao; Auinash Kalsotra
Journal:  Nat Commun       Date:  2015-11-04       Impact factor: 14.919

Review 10.  Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease.

Authors:  David Højland Ipsen; Jens Lykkesfeldt; Pernille Tveden-Nyborg
Journal:  Cell Mol Life Sci       Date:  2018-06-23       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.